Cargando…

Activating BRAF G469A Missense Mutation in a Pediatric Patient With High-Grade Glioma

Detalles Bibliográficos
Autores principales:	Kronish, Adam, DeNardo, Bradley, Kanach, Colin, Lulla, Rishi R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716068/ https://www.ncbi.nlm.nih.gov/pubmed/34965294 http://dx.doi.org/10.1093/jnen/nlab102

Ejemplares similares

Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation
por: Virzì, Anna Rita, et al.
Publicado: (2018)

Mutations in chromatin machinery and pediatric high-grade glioma
por: Lulla, Rishi R., et al.
Publicado: (2016)

The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma
por: Porcelli, Letizia, et al.
Publicado: (2015)

LGG-36. Analysis of BRAF-related mutations in pediatric low-grade glioma
por: Li, Shaoqun, et al.
Publicado: (2022)

LGG-23. OUTCOMES UTILIZING BRAF INHIBITION MONOTHERAPY IN BRAF(V600E) MUTATED PEDIATRIC LOW GRADE GLIOMAS
por: McThenia, Sheila, et al.
Publicado: (2023)

BRAF, GNAQ, and GNA11 mutations and copy number in pediatric low-grade glioma
por: Laviv, Yosef, et al.
Publicado: (2012)

Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
por: Toll, Stephanie A., et al.
Publicado: (2019)

Management of Inoperable Supra-Sellar Low-Grade Glioma With BRAF Mutation in Young Children
por: Howden, Kaitlyn, et al.
Publicado: (2021)

Addendum: Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
por: Toll, Stephanie A., et al.
Publicado: (2023)

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018)

Incidence of kiaa1549-braf fusion gene in Egyptian pediatric low grade glioma
por: Taha, Hala, et al.
Publicado: (2015)

Clinical and economic impact of molecular testing for BRAF fusion in pediatric low-grade Glioma
por: Rios, Juan David, et al.
Publicado: (2022)

Chromatin mutations in pediatric high grade gliomas
por: Voon, Hsiao P. J., et al.
Publicado: (2023)

Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas
por: Penman, Catherine Louise, et al.
Publicado: (2015)

Answer to the question from page 469
Publicado: (2013)

A Novel Missense Mutation in BRAF Caused Cardio-Facio-Cutaneous Syndrome
por: Hazan, Filiz, et al.
Publicado: (2013)

LGG-51. BRAF ALTERATIONS IN PEDIATRIC LOW-GRADE GLIOMAS: RESULTS FROM A BRAZILIAN COHORT
por: Restine, Felipe, et al.
Publicado: (2020)

A mouse model of brittle cornea syndrome caused by mutation in Zfp469
por: Stanton, Chloe M., et al.
Publicado: (2021)

LGG-17. CLINICAL OUTCOME OF PEDIATRIC LOW GRADE GLIOMA WITH POSITIVE BRAF-FUSION TREATED WITH MEK INHIBITOR
por: Dennis, T L Ku, et al.
Publicado: (2021)

Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600–Mutant Low-Grade Glioma
por: Bouffet, Eric, et al.
Publicado: (2023)

Fungal Planet description sheets: 469–557
por: Crous, P.W., et al.
Publicado: (2016)

Polymorphism rs13334190 in zinc finger protein 469 (ZNF469) is not a risk factor for keratoconus in a Saudi cohort
por: Kalantan, Hatem, et al.
Publicado: (2017)

LGG-08. MR Imaging of pediatric low-grade gliomas: Pretherapeutic differentiation ofBRAF V600E mutation,BRAF-Fused and Wild-Type tumors in patients without Neurofibromatosis-1
por: Trasolini, Andrew, et al.
Publicado: (2022)

Early molecular diagnosis of BRAF status drives the neurosurgical management in BRAF V600E-mutant pediatric low-grade gliomas: a case report
por: Piccolo, Gianluca, et al.
Publicado: (2022)

Pediatric high-grade glioma resources from the Children’s Brain Tumor Tissue Consortium
por: Ijaz, Heba, et al.
Publicado: (2020)

Pediatric Low-Grade Gliomas
por: Collins, Kelly L., et al.
Publicado: (2020)

LGG-55. OUTCOME OF BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION
por: Nobre, Liana, et al.
Publicado: (2020)

Pediatric diffuse hemispheric glioma H3 G34-mutant with gains of the BRAF locus: An illustrative case
por: Marlow, Christine, et al.
Publicado: (2023)

Identification of seven novel ZNF469 mutations in keratoconus patients in a Han Chinese population
por: Yu, Xiaoning, et al.
Publicado: (2017)

HGG-49. A PEDIATRIC THALAMIC HIGH-GRADE GLIOMA WITH H3F3A K27M AND BRAF V600E DOUBLE MUTATIONS
por: Terashima, Keita, et al.
Publicado: (2020)

TRLS-13. NOVEL PAN-RAF INHIBITOR BELVARAFENIB AS A PROMISING TARGETED THERAPY FOR BRAF-ALTERED PEDIATRIC LOW-GRADE GLIOMAS
por: Gonzalez, Maxine, et al.
Publicado: (2023)

Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR
por: Li, Daphne, et al.
Publicado: (2021)

Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma
por: Tholander, Bengt, et al.
Publicado: (2020)

AKT1 and BRAF mutations in pediatric aggressive fibromatosis
por: Meazza, Cristina, et al.
Publicado: (2016)

LGG-18. EVEROLIMUS TREATMENT IN PEDIATRIC PATIENTS AFFECTED BY LOW-GRADE GLIOMAS (pLGG) NON-TSC, BRAF v600-WT
por: Cacchione, Antonella, et al.
Publicado: (2020)

Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes
por: Huang, Tina, et al.
Publicado: (2018)

Correction to Lancet Planet Health 2019; 3: e469–77
Publicado: (2021)

Medical Treatment of Pediatric Low-Grade Glioma
por: Lim, Yeon Jung
Publicado: (2022)

Topographic correlates of driver mutations and endogenous gene expression in pediatric diffuse midline gliomas and hemispheric high-grade gliomas
por: Kazarian, Eve, et al.
Publicado: (2021)

ECOA-10. Integrated genomic and clinical analysis of BRAF-mutated glioma in adults
por: Langat, Pinky, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r6u9lfsbqogqrr785i625t5kaq